Sridevi Devaraj, PhD, DABCC, FACB
Department of Pathology and Immunology, Baylor College of Medicine; Department of Clinical Chemistry and POCT, Texas Children’s Microbiome Center, Texas Children's Hospital, Houston, Texas, USA
S. Devaraj, PhD graduated from the Post-Graduate Institute of Basic Medical Sciences, Madras, India, with a PhD in Biochemistry and thereafter undertook fellowships at the University of Texas Southwestern Medical Center, Dallas in Human Nutrition and Clinical Chemistry (1994-1997). In 1999, she became Assistant Professor of Clinical Biochemistry and Human Metabolism in the Department of Pathology at UT Southwestern. In 2002, she joined UC Davis as Assistant Professor in the Laboratory for Atherosclerosis and Metabolic Research and Director of Toxicology and Special Chemistry in the Department of Pathology at the University of California, Davis Medical Center in Sacramento, CA, where she quickly rose to the rank of Professor. Also, she served as the Laboratory Core Director of the General Clinical Research Center and Co-Director of the Translational Program at UC Davis Medical Center. In 2011, she moved to Texas Children’s Hospital and Baylor College of Medicine in Houston, TX. Presently, Dr. Devaraj is the Director of Chemistry and POCT at Texas Children’s Hospital, Professor of Pathology and Immunology at Baylor College of Medicine and Associate Director of the Texas Children’s Microbiome Center. She is also the Director of the Clinical chemistry resident rotation and the ComACC accredited clinical chemistry fellowship program at TCH/BCM.
To date, she has published over 300 original papers and invited reviews in the areas of clinical biochemistry, diabetes and atherosclerosis, metabolism, nutrition and free radical biology. She has received numerous awards for her work including the George Grannis Award from the National Academy of Clinical Biochemistry and an award for Outstanding Achievements by a Young Investigator in Clinical Chemistry and Outstanding Contributions to Clinical Chemistry in Science and technology from the American Association Of Clinical Chemistry as well as the Merck Young Investigator Award in Atherosclerosis. She is presently a member of the American Association of Clinical Chemistry, National Academy of Clinical Biochemistry and the American Heart Association and American Society of Clinical Pathology. She is on the Editorial Board of several journals including Atherosclerosis, Archives of Pathology and Laboratory Medicine, Clinica Chimica Acta, Annals of Clinical Biochemistry, etc. Presently, her major research interests are obesity, inflammation, oxidative stress, gut microbiome and diabetes, metabolic syndrome and nutritional modulation of risk factors for heart disease/diabetes. She is also very interested in pediatric biomarkers of disease. Her research has been funded by the NIH, ADA, AHA and other sponsors.